Stock ELEV ELEVATION ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Elevation Oncology, Inc.

Equities

ELEV

US28623U1016

Real-time Estimate Cboe BZX
Other stock markets
 09:42:12 2024-06-05 EDT 		5-day change 1st Jan Change
3.655 USD -0.88% Intraday chart for Elevation Oncology, Inc. -3.72% +586.69%
05-31 Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target MT
05-14 Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ELEVATION ONCOLOGY, INC.
Bio Therapeutic Drugs
-2.45%-3.72%+586.69%+4.17% - 201M
Neutral
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ELEV Stock
  4. Charts Elevation Oncology, Inc.
  5. Comparison Chart